65% of people with hybrid immunity neutralised Covid-19’s Omicron variant: Study by Kerala doctor

Dr Padmanabha Shenoy, a rheumatologist and medical director at CARE Hospital in Kochi said that hybrid immunity has better efficacy against the spread of Omicron than two doses of COVID-19 vaccines.

Kochi: Hybrid immunity is effective in preventing the spread of the Omicron variant of the COVID-19 virus, reveals the study conducted by Dr Padmanabha Shenoy, a rheumatologist and medical director at CARE Hospital in Kochi.

Speaking to ANI, Dr Shenoy said that hybrid immunity has better efficacy against the spread of Omicron than two doses of COVID-19 vaccines. "This is precisely the reason why India is seeing much less number of fatalities during the third wave. When the US is reporting 3,500 deaths per day, our country is hardly reporting 300-350. It is lesser than 10 per cent of what was expected. The predominant reason behind this is hybrid immunity," he stated.

"For last one and half years, we have been monitoring around 2000 patients in Kochi who were either vaccinated or infected or the ones who were vaccinated after recovering from the infection. When somebody gets vaccinated after recovering from the infection, they develop hybrid immunity against the infection."